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The increase in obesity in the U.S. and elsewhere can be
explained by a variety of factors, as outlined by David
Allison and his colleagues. Not only is the fast food diet a
factor, but also are changes in ambient temperature, obe-
sity-causing psychoactive molecules, associative sorting,
changes in smoking habits, and reduction in sleep. In
particular is the increase in visceral fat, which is asso-
ciated with insulin resistance. We have shown in experi-
mental animals that omentectomy increases insulin
sensitivity implicating visceral fat per se as an important
factor. We have followed longitudinally changes in organ
function and crosstalk in a large animal model, rendered
overweight by a high fat, hypercaloric diet. In normal ani-
mals, like in normal humans, there is a wide range of
adiposity as well as visceral and subcutaneous fat deposi-
tion. Feeding fat increases visceral and subcutaneous fat
with little change in body weight. Physiologic changes
occur with absolutely no change in fasting glucose: most
predictive of insulin resistance is relative reduction in
metabolic clearance of insulin by liver, and a modest
increase in beta cell sensitivity to glucose. The latter
changes result in hyperinsulinemia. Change in insulin sen-
sitivity is also predicted by change in liver insulin clearance,
implicating metabolic clearance of insulin as the primary
factor in development of the insulin resistance syndrome.
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